Clinical trials
Spontaneous Intracerebral Hemorrhage clinical trials
Below are recruiting spontaneous intracerebral hemorrhage clinical trials, each written for real people, not researchers. We’re tracking 39 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07761507Recruiting
Ear stimulation to help wake up after brain bleed surgery
This trial tests a gentle ear stimulation device that may help people regain consciousness after surgery for a brain bleed. It is done while the person is in the hospital and may improve recovery.
BeijingAges 18–75 - NCT07187687Recruiting
Early minimally invasive clot removal for brain hemorrhage
This study tests if removing a large brain clot early using a small tube and clot-dissolving medicine can improve recovery after a hemorrhagic stroke. It is for people with a moderate to large bleed who can start treatment within 12 hours of symptoms.
Guangdong, YuexiuAges 18 years+ - NCT04686877Recruiting
Surgery to remove deep brain bleeding with urokinase
This trial tests whether a targeted (stereotactic) procedure to remove deep brain bleeding, combined with a medicine called urokinase, is safer and works better than standard care. It focuses on people whose bleeding is in the deep brain and who are able to undergo surgery within a specific time window.
Fuzhou, FujianAges 40 years+ - NCT07728734Enrolling by invitation
Predicting recovery after a brain bleed
This study is testing a way to predict how well people will recover after a brain bleed (intracerebral hemorrhage). It uses information from the first 24 hours to help doctors and families understand the chances of getting better.
Badalona, BarcelonaAges 18 years+ - NCT05504941Recruiting
Testing a treatment target map in sudden brain bleeding
This study looks at a special scan (DSA, done with contrast dye) to find a likely “target” that doctors can use when treating sudden brain bleeding. It’s meant to help doctors better understand where treatment may be needed soon after symptoms start.
BaselAges 18 years+ - NCT05836831RecruitingPhase 4
Tranexamic acid for sudden brain bleeding after stroke
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
Guntur, Andhra PradeshAges 18–99 - NCT05975398Recruiting
Study of severe spontaneous brain bleeding in China
This study looks at people with a severe type of brain bleed that happens on its own (not from an injury). It compares different treatments to find the best way to help patients recover.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06429332RecruitingPhase 4
Care bundle study for brain bleed on CT scan
This trial is testing a set of standard care steps (a 'care bundle') for people who have a sudden brain bleed (intracerebral hemorrhage) that shows up on a CT scan. It aims to see if this bundle improves recovery and outcomes.
Oklahoma City, OklahomaAges 18 years+ - NCT06763055RecruitingPhase 3
Study of two drugs for spontaneous brain bleed recovery
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Sydney, New South WalesAges 18–80 - NCT06799390Recruiting
Ear stimulation after brain bleed
This study tests whether gentle electrical stimulation through the ear (called auricular VNS) can help people recover after a bleed in the upper part of the brain. It aims to reduce inflammation and improve outcomes when started within 48 hours.
St Louis, MissouriAges 18 years+ - NCT06918964Recruiting
Ear nerve stimulation for recent brain bleed
This trial tests a gentle electrical ear stimulation device (taVNS) to see if it helps people recover after a recent brain bleed. It is for adults who had a specific type of bleed within the last 3 days and are generally stable otherwise.
Beijing, Beijing MunicipalityAges 18–80 - NCT07088250Recruiting
Statins for Treating Brain Bleeding
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
Anqing, AnhuiAges 18–80 - NCT07166146Recruiting
Recovery timing after brain bleed surgery
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
BeijingAges 18–80 - NCT07234955Recruiting
Minimally invasive surgery for deep brain bleeding
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
Ho Chi Minh City, Ho Chi MinhAges 18–80 - NCT07246473Recruiting
Non-invasive ultrasound for brain bleed clearance
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
Wuhu, AnhuiAges 18–80 - NCT07338175RecruitingPhase 3
Testing minocycline for brain bleeding recovery
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
Beijing, Beijing MunicipalityAges 18–80 - NCT07458815Recruiting
Vitamin D for stroke recovery after brain bleed
This trial tests whether vitamin D supplements can help people recover after a specific type of stroke (intracerebral hemorrhage). It is for adults who had a moderate-sized bleed in the upper part of the brain within the last 4 days and were otherwise independent before the stroke.
Hong KongAges 18–90 - NCT06868511RecruitingPhase 3
Minimally invasive clot removal with tenecteplase for deep brain bleed
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Beijing, ChinaAges 18–80 - NCT06670456Recruiting
Brain Bleed Study (Without Surgery)
This study is for people who had a spontaneous brain bleed and did not have surgery. It aims to learn more about their recovery and health over time.
Fuzhou, FujianAges 18 years+ - NCT07458880Recruiting
Triple blood pressure pill after a brain bleed
This trial tests whether a combination of three blood pressure medicines can better control blood pressure after a brain bleed (intracerebral hemorrhage). It may help prevent another bleed or stroke.
Hong Kong, Hong KongAges 18 years+ - NCT07077343Recruiting
AI-guided blood clot removal vs. standard care for brain bleeding
This study compares a new AI-guided procedure to remove blood clots from the brain with standard medical treatment. It may help people who had a stroke from high blood pressure and have a medium-sized bleed in the upper part of the brain.
Beijing, Beijing MunicipalityAges 18–80 - NCT06816641Recruiting
Surgery for spontaneous brain bleed: outcomes and factors
This trial studies how well surgery works for people who have a spontaneous brain bleed (not from injury) and looks at factors that might affect recovery. It may help doctors better predict who benefits from surgery.
SohagAges 20–70 - NCT03936361RecruitingPhase 3
Statins after a stroke bleed in the brain (Phase 3)
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Boston, MassachusettsAges 50 years+ - NCT07208097Recruiting
Brain bleed clot dissolving with tNK for stroke recovery
This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.
Suzhou, AnhuiAges 18–80
Hear when a new Spontaneous Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for spontaneous intracerebral hemorrhage?
- Yes. Clin2 currently lists 39 recruiting spontaneous intracerebral hemorrhage studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a spontaneous intracerebral hemorrhage trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a spontaneous intracerebral hemorrhage trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.